Pelviva Licensing Opportunity: Unique product, brand, and technology
Femeda will commence discussions with licensing partners in early 2018 for all European and Global markets.
We are inviting approaches from potential corporate partners who share our innovative vision and commitment to rapidly role out our life changing product to millions of women worldwide.
Detailed regulatory packages completed. CE marked in Europe (Class IIA), FDA pre submission meetings completed and FDA submission package available.
We can ensure the supply for both product launch and commercial demand.